Email this article Xenon as an anesthetic of choice for full mouth debridement in a child with drug-resistant epilepsy: A clinical case
- Authors: Khaliullin D.M.1, Lazarev V.V.2,3, Shugailov I.A.4, Gracheva E.S.5
-
Affiliations:
- Dental Forte Elite LLC
- The Russian National Research Medical University named after N.I. Pirogov
- V.F. Voyno-Yasenetsky Scientific and Practical Center of Specialized Medical Care for Children
- Russian Medical Academy of Continuous Professional Education
- Good Dental LLC
- Issue: Vol 28, No 5 (2024)
- Pages: 506-511
- Section: Case reports
- URL: https://journals.rcsi.science/1728-2802/article/view/313563
- DOI: https://doi.org/10.17816/dent633857
- ID: 313563
Cite item
Open Access
Access granted
Subscription Access
Abstract
Background: Outpatient dental care in children with epilepsy (particularly drug-resistant epilepsy) is challenging for anesthesiologists in terms of selecting appropriate anesthesia methods and agents, as well as for dentists in terms of improving treatment efficacy and quality while minimizing intervention time. General anesthetics may trigger seizures in patients with epilepsy, including those with drug-resistant epilepsy. As a result, selecting the appropriate anesthetic is critical during preparation stages and anesthetic management in these patients.
Case description: A clinical case of full mouth debridement in a 3-year-old child with drug-resistant epilepsy is presented to demonstrate the efficacy of xenon as an inhalational anesthetic in patients with drug-resistant epilepsy. Combination inhalation anesthesia with xenon was used.
There were no signs of seizures during surgery and within two days after anesthesia.
Conclusion: Xenon may be a viable inhalational anesthetic for patients with drug-resistant epilepsy.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Dinar M. Khaliullin
Dental Forte Elite LLC
Email: dr170489@yandex.ru
ORCID iD: 0000-0003-2771-3134
SPIN-code: 7165-1859
MD, Cand. Sci. (Medicine)
Russian Federation, Republic of Tatarstan, Naberezhnye ChelnyVladimir V. Lazarev
The Russian National Research Medical University named after N.I. Pirogov; V.F. Voyno-Yasenetsky Scientific and Practical Center of Specialized Medical Care for Children
Author for correspondence.
Email: lazarev_vv@inbox.ru
ORCID iD: 0000-0001-8417-3555
SPIN-code: 4414-0677
MD, Dr. Sci. (Medicine), Professor
Russian Federation, Moscow; MoscowIgor A. Shugailov
Russian Medical Academy of Continuous Professional Education
Email: 9978753@mail.ru
ORCID iD: 0000-0001-5304-6078
SPIN-code: 5681-7569
MD, Dr. Sci. (Medicine), Professor
Russian Federation, MoscowElena S. Gracheva
Good Dental LLC
Email: murzic_elena@icloud.com
ORCID iD: 0000-0002-2758-8065
Russian Federation, Republic of Tatarstan, Naberezhnye Chelny
References
- Miao M, Han Y, Zhang Y, et al. Epileptiform EEG discharges during sevoflurane anesthesia in children: A meta-analysis. Clin Neurophysiol. 2022;143:48–55. doi: 10.1016/j.clinph.2022.08.019
- Tanaka S, Oda Y, Ryokai M, et al. The effect of sevoflurane on electrocorticographic spike activity in pediatric patients with epilepsy. Paediatr Anaesth. 2017;27(4):409–416. doi: 10.1111/pan.13111
- Vakkuri A, Yli-Hankala A, Särkelä M, et al. Sevoflurane mask induction of anaesthesia is associated with epileptiform EEG in children. Acta Anaesthesiol Scand. 2001;45(7):805–811. doi: 10.1034/j.1399-6576.2001.045007805.x
- Liu XY, Shi T, Yin WN, et al. Interictal epileptiform discharges were associated with poorer cognitive performance in adult epileptic patients. Epilepsy Res. 2016;128:1–5. doi: 10.1016/j.eplepsyres.2016.09.022
- Lu L, Xiong W, Zhang Y, et al. Propofol-induced refractory status epilepticus at remission age in benign epilepsy with centrotemporal spikes: A case report and literature review. Medicine (Baltimore). 2019;98(27):e16257. doi: 10.1097/MD.0000000000016257
- Perucca E, Perucca P, White HS, Wirrell EC. Drug resistance in epilepsy. Lancet Neurol. 2023;22(8):723–734. doi: 10.1016/S1474-4422(23)00151-5
- Korsunsky G. Xenon. Int Anesthesiol Clin. 2015;53(2):40–54. doi: 10.1097/AIA.0000000000000049
- Maze M, Laitio T. Neuroprotective properties of xenon. Mol Neurobiol. 2020;57(1):118–124. doi: 10.1007/s12035-019-01761-z
- Zhang Y, Zhang M, Liu S, et al. Xenon exerts anti-seizure and neuroprotective effects in kainic acid-induced status epilepticus and neonatal hypoxia-induced seizure. Exp Neurol. 2019;322:113054. doi: 10.1016/j.expneurol.2019.113054
- Hanada T. Ionotropic Glutamate receptors in epilepsy: a review focusing on AMPA and NMDA receptors. Biomolecules. 2020;10(3):464. doi: 10.3390/biom10030464
- Campos-Pires R, Hirnet T, Valeo F, et al. Xenon improves long-term cognitive function, reduces neuronal loss and chronic neuroinflammation, and improves survival after traumatic brain injury in mice. Br J Anaesth. 2019;123(1):60–73. doi: 10.1016/j.bja.2019.02.032
- Zhao CS, Li H, Wang Z, Chen G. Potential application value of xenon in stroke treatment. Med Gas Res. 2018;8(3):116–120. doi: 10.4103/2045-9912.241077
- Zhang M, Cui Y, Cheng Y, et al. The neuroprotective effect and possible therapeutic application of xenon in neurological diseases. J Neurosci Res. 2021;99(12):3274–3283. doi: 10.1002/jnr.24958
- Sabinina TS, Bagaev VG, Alekseev IF. Prospects for applying xenon curative properties in pediatrics. Pediatric Pharmacology. 2018;15(5):390–395. EDN: VBURNO doi: 10.15690/pf.v15i5.1961
Supplementary files
